CAMBRIDGE, MA, July 19th, 2022: Matterworks, Inc., developers of the world's most powerful metabolomics platform, which accelerates the discovery, development, and manufacturing of biologics and gene therapies, today announces updates to its Board of Directors. Learn More
Board of Directors updates
